{
  "id": "color-blindness",
  "title": "Color Blindness",
  "lang": "en",
  "source_lang": "en",
  "summary": "Color blindness encompasses inherited and acquired conditions that reduce or eliminate the ability to distinguish colors.",
  "category": "health",
  "subcategory": "medicine",
  "type": "concept",
  "aliases": [
    "Colour blindness",
    "color vision deficiency",
    "colour vision deficiency",
    "defective color vision",
    "dyschromatopsia"
  ],
  "generated_at": "2026-10-13",
  "model": "pro/gpt-6.1-sol",
  "url": "https://aiwiki.page/en/color-blindness/",
  "translations": {
    "zh-Hans": {
      "url": "https://aiwiki.page/zh/color-blindness/",
      "json": "https://aiwiki.page/zh/color-blindness.json"
    }
  },
  "sections": [
    {
      "heading": "",
      "text": "Color blindness, more precisely called color vision deficiency, is a group of conditions in which the perception or discrimination of colors differs from typical human color vision. Most affected people can see colors but have difficulty distinguishing particular shades; complete absence of color vision is uncommon. Red–green deficiencies are the most frequent forms, while blue–yellow deficiencies and conditions involving severely reduced or absent color vision are rarer. (medlineplus.gov)\n\nColor vision depends on light-sensitive cone cells in the retina and the processing of their signals by the brain. Most common inherited deficiencies result from variations in genes encoding cone photopigments, with patterns of inheritance that help explain differences in frequency between sexes. Color discrimination can also be altered by diseases or injuries affecting the eyes or brain, certain medicines, and aging. Common inherited red–green deficiencies generally do not reduce visual acuity, whereas some rarer congenital conditions involve additional visual impairments. (medlineplus.gov)\n\nThe subject connects visual physiology and genetics with clinical diagnosis, education, and the accessibility of information. Color-based classroom materials, workplace tasks, and digital interfaces can create difficulties that depend on both the person's visual capabilities and how information is presented. Its study therefore includes classification, causes, population distribution, testing, functional effects, assistive approaches, and the history of research into color perception. (nei.nih.gov)"
    },
    {
      "heading": "Terminology and Clinical Scope",
      "text": "Color vision deficiency denotes a group of conditions in which the perception and discrimination of colors differ from typical color vision. Color blindness is the familiar umbrella term, but it usually does not mean that a person sees only black, white, and gray. Most affected people perceive colors while having difficulty distinguishing particular colors or shades. The term therefore encompasses a range of selective discrimination difficulties as well as rare conditions involving a complete absence of color perception; it does not describe a single, uniform visual experience. (nei.nih.gov)\n\nThe difficulty may concern differences in hue, distinctions between shades of a color, or how bright colors appear. Labels such as red–green deficiency identify broad patterns of color confusion rather than an inability to see every object described as red or green. For example, inherited red–green deficiencies can make some shades of red, yellow, and green difficult to distinguish. Inherited blue–yellow deficiencies can involve confusion between blue and green or between dark blue and black. These examples illustrate why the clinical description concerns discrimination between colors, not simply the presence or absence of named colors in perception. (nei.nih.gov)\n\nColor discrimination is distinct from visual acuity, the sharpness of vision. The common inherited red–green and blue–yellow deficiencies alter color perception without themselves reducing visual acuity: a person may see an object's detail clearly while having difficulty distinguishing its color from another. Conversely, severe cone disorders can affect both color perception and acuity. Blue cone monochromacy, for instance, combines severely reduced color vision with poor visual acuity and may also cause light sensitivity and involuntary eye movements. Thus, a color-vision diagnosis alone does not establish the extent of other visual impairment. (medlineplus.gov)\n\nThe clinical scope also distinguishes inherited from acquired deficiencies. The most common forms are inherited through genes and are present from birth, although their effects may not be recognized until later. Common inherited color-discrimination difficulties generally remain stable over time. Acquired deficiencies develop through disease, injury, or other exposures affecting the eyes or the brain; their course depends on the underlying condition. Examples include changes associated with glaucoma, multiple sclerosis, and cataracts, as well as certain medicines. “Color blindness” therefore names a perceptual outcome without, by itself, specifying its cause. (nei.nih.gov)\n\nAchromatopsia is a more specific diagnosis, not a synonym for all color vision deficiency. Complete achromatopsia entails an inability to perceive color, with vision restricted to black, white, and shades of gray; incomplete achromatopsia retains some color perception. Unlike common selective deficiencies, achromatopsia typically also involves markedly reduced visual acuity, sensitivity to light and glare (photophobia), and involuntary back-and-forth eye movements (nystagmus). Its inclusion within the broad terminology of color blindness must therefore be distinguished from the much more common situation in which color discrimination is altered but visual sharpness is preserved. (medlineplus.gov)"
    },
    {
      "heading": "Biological Basis of Color Vision",
      "text": "The retina, the light-sensitive tissue at the back of the eye, contains two principal classes of photoreceptor: rods and cones. Rods support vision at low light levels, whereas cones provide daylight vision and the signals needed for ordinary color discrimination. Both convert absorbed light into electrical signals, which retinal circuits process before transmitting information through the optic nerve to the brain. Color perception therefore depends on both the receptors’ sensitivity to light and the nervous system’s processing of their outputs; it is not a property generated by an individual cone in isolation. (medlineplus.gov)\n\nTypical human color vision uses three cone classes, designated S, M, and L for their preferential sensitivity to short, medium, and long wavelengths. Their photopigments have broad, overlapping absorption spectra rather than responding exclusively to three separate colors. In a 1980 study, James K. Bowmaker and H. J. A. Dartnall measured pigment absorption in individual photoreceptors from one human retina. Mean absorption maxima were approximately 420 nanometers for S-cone pigments, 534 nanometers for M-cone pigments, and 563 nanometers for L-cone pigments. These are pigment absorption measurements, not fixed boundaries dividing the visible spectrum into “blue,” “green,” and “red.” In particular, the L-cone pigment’s maximum lies well short of the wavelengths ordinarily described as red. The labels “blue cone,” “green cone,” and “red cone” are therefore convenient shorthand, not descriptions of the only colors those cells detect. (physoc.onlinelibrary.wiley.com)\n\nThe wavelength sensitivity of each cone class depends on its opsin, the protein component of its visual photopigment. Different opsins give the three classes different spectral responses, allowing the same incident light to stimulate them to different degrees. Absorption must also be coupled to a functioning cellular signaling system. This conversion of light into an electrical response, called phototransduction, involves changes in ion movement across the photoreceptor membrane. In cones, cyclic nucleotide-gated channels are important components of that process. Thus, a cone can fail to supply useful visual information because its pigment is altered or because the machinery converting absorbed light into an electrical signal is impaired. (pubmed.ncbi.nlm.nih.gov)\n\nRetinal processing compares cone outputs rather than simply sending three independent color labels to the brain. Cone signals pass through bipolar cells to retinal ganglion cells, some of which receive opposing inputs from different cone classes. Two important arrangements compare L-cone with M-cone signals, and S-cone signals with combined L- and M-cone signals. These comparisons underlie pathways conventionally described as red–green and blue–yellow opponency. In 1994, Dennis M. Dacey and Barry B. Lee identified a distinct small bistratified ganglion-cell type in macaque retina that carries an excitatory S-cone signal opposed by L- and M-cone input. Such findings establish that comparison of spectral signals begins within the retina, before further processing in the brain. (pubmed.ncbi.nlm.nih.gov)\n\nColor vision deficiency reduces or alters the information available to these comparisons. An abnormal L- or M-cone opsin can change a cone class’s wavelength sensitivity; loss of a functional cone contribution removes one source of comparison altogether. Impaired S-cone function similarly disrupts distinctions that depend on short-wavelength input. These changes do not necessarily prevent light detection or eliminate all color perception: common inherited red–green deficiencies affect particular color distinctions while leaving visual acuity intact. More extensive disruption of cone signaling, including defective ion-channel function in achromatopsia, can impair both color discrimination and daylight vision. The biological distinction is between altered spectral sampling and impaired cone function, although both can occur within the broader group of color vision disorders. (medlineplus.gov)"
    },
    {
      "heading": "Principal Types of Color Vision Deficiency",
      "text": "Color vision deficiencies are classified by the cone contributions affected and by the number of spectrally distinct signals available for color discrimination. In anomalous trichromacy, three cone contributions remain, but one differs from the usual spectral response; in dichromacy, only two distinct cone contributions support color vision. Monochromacy describes vision supported by a single functional cone class or, in rod monochromacy, by rods without functional cone contributions. These are functional categories, not simply counts of cone cells physically present in the retina. Anomalous trichromacy can range from mild to severe, so people sharing a classification need not have identical color discrimination. (ncbi.nlm.nih.gov)\n\nProtan and deutan deficiencies form the principal red–green groups. Protanomaly involves an altered long-wavelength-sensitive (L) cone contribution, whereas deuteranomaly involves an altered medium-wavelength-sensitive (M) contribution; both are anomalous trichromacies. In protanopia, a distinct functional L contribution is unavailable, leaving S- and M-cone signals; in deuteranopia, the M contribution is unavailable, leaving S- and L-cone signals. Both are dichromacies. The distinction is therefore between an altered spectral contribution and the loss of an independently useful contribution, rather than merely “weak” and “strong” versions of the same condition. Deuteranomaly is the most common red–green deficiency. Protan defects can additionally make long-wavelength reds appear less bright. “Red–green” identifies a pattern of impaired discrimination: difficulties can involve some shades of red, yellow, and green, rather than every object bearing those color names. (ncbi.nlm.nih.gov)\n\nTritan deficiencies affect the short-wavelength-sensitive (S) cone contribution. Tritanomaly denotes anomalous trichromatic color vision involving this contribution, while tritanopia denotes dichromacy without an independently functional S contribution. The conventional label blue–yellow deficiency does not exhaust the resulting confusions. Tritanomaly can impair discrimination between blue and green and between yellow and red; tritanopia can produce confusions between blue and green, purple and red, and yellow and pink. These examples describe affected color relationships, not a universal replacement of one named color by another. Inherited tritan defects, like common inherited red–green defects, ordinarily alter color discrimination without reducing visual acuity. (ncbi.nlm.nih.gov)\n\nIn complete achromatopsia, all three cone classes lack useful function, and vision is mediated by rods; this is also called rod monochromacy. Color discrimination is absent. Incomplete achromatopsia retains some cone function and limited color discrimination, although discrimination remains impaired across the protan, deutan, and tritan axes. Both forms can include photophobia, meaning sensitivity to light and glare, and nystagmus, meaning involuntary oscillatory eye movements, together with reduced visual acuity. GeneReviews reports best visual acuity of 20/200 or worse in complete achromatopsia, while incomplete cases may reach 20/80. Nystagmus typically develops within the first weeks after birth. The incomplete form generally has less pronounced visual impairment, but it is not equivalent to an isolated red–green or tritan deficiency. (ncbi.nlm.nih.gov)\n\nBlue cone monochromacy differs from complete achromatopsia because S cones and rods remain functional, whereas L- and M-cone function is absent or severely impaired. Its name identifies the surviving cone class; it does not mean that every object appears blue. Color vision is severely reduced, and limited discrimination can occur under intermediate illumination through comparison of rod and S-cone signals. Associated features include poor visual acuity, photophobia, and nystagmus. Although sometimes grouped with incomplete achromatopsia, its preserved S-cone contribution distinguishes it from complete rod monochromacy and from incomplete achromatopsia with more broadly retained cone function. (medlineplus.gov)"
    },
    {
      "heading": "Genetic Causes and Inheritance",
      "text": "The principal genes involved in inherited red–green color vision deficiencies are OPN1LW and OPN1MW, which encode the long-wavelength-sensitive (L) and medium-wavelength-sensitive (M) cone opsins. They lie next to one another on the X chromosome, in an array usually containing one OPN1LW copy and one or more OPN1MW copies. Their closely similar DNA sequences make the array susceptible to rearrangements during recombination: genetic material may be deleted, or portions of the two genes may combine into a hybrid opsin gene. These changes can eliminate a functional pigment or alter its wavelength sensitivity, reducing the distinction between L- and M-cone signals. A nearby locus control region regulates gene expression; deletion of this region can prevent production of both pigments and cause blue cone monochromacy, in which S cones remain the only functional cone class. (medlineplus.gov)\n\nInherited red–green deficiencies and blue cone monochromacy generally follow an X-linked recessive pattern. In the usual XY chromosome arrangement, a male has only one X chromosome, so a disease-causing alteration on that chromosome can be expressed without a second altered copy. A female with two X chromosomes and an alteration on only one is generally a carrier. Under the standard inheritance model, a carrier mother and an unaffected father have, for each son, a 50% probability of an affected child and, for each daughter, a 50% probability of a carrier child. An affected father and a mother carrying no relevant alteration have carrier daughters and unaffected sons: the father passes his X chromosome to daughters and his Y chromosome to sons, so there is no father-to-son transmission of the X-linked alteration. (medlineplus.gov)\n\nInherited tritan deficiency associated with OPN1SW instead follows an autosomal dominant pattern. This gene encodes the short-wavelength-sensitive cone opsin; a disease-causing alteration in one copy can be sufficient to impair S-cone function. Documented variants change amino acids in the opsin protein, making it partially or completely nonfunctional. Unlike X-linked inheritance, this pattern permits transmission from either parent to children of either sex, including father-to-son transmission. An affected parent with one altered copy and one unaffected copy has a 50% probability of transmitting the altered copy in each pregnancy. This describes transmission of the allele, rather than a prediction of the precise degree of color-discrimination impairment. (medlineplus.gov)\n\nAchromatopsia usually follows an autosomal recessive pattern, requiring disease-causing variants in both copies of the same associated gene. CNGA3 and CNGB3 are its most common genetic causes and encode different subunits of the cone cyclic nucleotide-gated channel. Unlike opsin variants, which affect the light-sensitive pigment itself, these alterations disrupt a downstream component of phototransduction. Normally, changes in channel opening regulate ion movement across the cone membrane and thereby change its electrical signal. Defective or insufficient channel subunits impair that response. If both parents carry a disease-causing variant in the same achromatopsia-associated gene, the standard probabilities for each pregnancy are 25% affected, 50% unaffected carrier, and 25% unaffected non-carrier; these probabilities apply to either sex. (medlineplus.gov)\n\nAn inherited genotype is therefore distinct from its visual phenotype. Genetic changes may shift an opsin’s spectral sensitivity, prevent pigment production, or impair cone signaling without directly altering the pigment. Not every sequence difference causes a clinically significant deficiency: the common OPN1LW Ser180Ala variation, which substitutes alanine for serine at amino-acid position 180, contributes to subtle differences within normal color vision and can also influence the severity of an existing red–green defect. The functional consequence depends on the particular alteration and, for the X-linked opsin array, on which genes are expressed—not simply on the presence of a variant in a color-vision gene. (medlineplus.gov)"
    },
    {
      "heading": "Acquired Color Vision Changes",
      "text": "Acquired color vision deficiency results from disease, injury, or exposure affecting the visual system rather than from the inherited photopigment changes responsible for common congenital red–green deficiencies. Its causes can be organized anatomically: damage to the retina alters the visual information generated in the eye; damage to the optic nerve disrupts its transmission; and disease or injury affecting visual-processing regions of the brain interferes with its interpretation. Changes in the eye’s lens form a separate optical mechanism, modifying the light reaching otherwise functioning retinal receptors. Common inherited red–green deficiencies are generally stable, whereas acquired changes can develop later and follow the course of the underlying disorder. (medlineplus.gov)\n\nAt the retinal level, documented causes include age-related macular degeneration and retinal injuries. Retinal detachment, in which the light-sensitive tissue separates from its normal position at the back of the eye, is one example; laser injuries can also impair color vision. These conditions affect the tissue that receives light, rather than merely changing a person’s ability to identify color names. They differ from cataracts, which alter incoming light before it reaches the retina. In cataract formation, lens proteins clump together, producing cloudiness that obstructs light transmission; the lens may also become yellow or brown, changing the appearance of colors. Thus, diminished colorfulness associated with cataract need not indicate an inherited cone-pigment deficiency. (nei.nih.gov)\n\nGlaucoma is an optic-nerve disorder associated with acquired color vision deficiency. Its damage affects the nerve carrying retinal information to the brain and may progress alongside other visual losses. Multiple sclerosis provides another documented association: demyelination can disrupt optic-nerve signaling, and optic neuritis, an inflammation of that nerve, can impair color perception. The resulting disturbance is not restricted to one universal confusion pattern. A 1991 investigation of 32 patients with multiple sclerosis or optic neuritis found reduced chromatic sensitivity but no consistent wavelength-specific defect across the group; a subsequent analysis from the Optic Neuritis Treatment Trial likewise found no single type of color defect consistently associated with optic neuritis. (nei.nih.gov)\n\nDamage farther along the visual pathway can affect cerebral processing of color. MedlinePlus identifies disease of brain regions involved in visual processing as a cause of acquired deficiency, while the National Eye Institute includes brain injury and some tumors among documented causes. Tumors may impair vision by affecting the optic nerve or exerting pressure on the brain, so their anatomical effects are not necessarily confined to cortical processing. These mechanisms distinguish acquired neurological color disturbances from inherited deficiencies originating in retinal photopigments. (medlineplus.gov)\n\nMedication and chemical exposure provide additional causes. Chloroquine, used to treat malaria, is a documented example of a drug associated with acquired color vision deficiency; organic solvents are another recognized exposure category. Occupational studies provide specific evidence for styrene. In 1995, T. Eguchi and colleagues compared 64 styrene-exposed male workers in Japan with 69 controls of the same mean age, 38 years. The exposed workers had significantly poorer color discrimination, and impairment correlated with a urinary styrene metabolite after adjustment for several confounding variables. Defects were predominantly blue–yellow in both groups, although some participants showed more complex losses. These findings document an exposure-associated disturbance rather than a congenital subtype; they do not establish that every exposed worker develops the same deficit. (medlineplus.gov)"
    },
    {
      "heading": "Prevalence and Population Distribution",
      "text": "Inherited red–green deficiency is the most common form of altered color vision, but its prevalence differs by sex and population ancestry. The commonly cited estimates of approximately 1 in 12 males (about 8%) and 1 in 200 females (0.5%) apply to populations of Northern European ancestry; they are not universal population rates. MedlinePlus Genetics reports lower frequencies in almost all other populations studied. These figures describe red–green deficiency specifically, rather than every inherited or acquired condition affecting color perception. The marked sex difference principally reflects X-linked recessive inheritance involving genes on the X chromosome, a mechanism discussed separately under genetic causes. (medlineplus.gov)\n\nThe rarer inherited conditions have different distributions. Inherited blue–yellow, or tritan, deficiency is estimated to occur in fewer than 1 in 10,000 people worldwide, with males and females affected equally. Blue cone monochromacy has an estimated worldwide frequency of approximately 1 in 100,000 people and, like red–green deficiency, affects males much more often than females. These estimates concern distinct inherited disorders: neither is a rate for all blue–yellow discrimination problems, which may also arise from acquired disease. The different sex distributions accord with their inheritance patterns—autosomal dominant for inherited tritan deficiency and X-linked recessive for blue cone monochromacy. (medlineplus.gov)\n\nAchromatopsia is estimated to affect approximately 1 in 30,000 people worldwide; complete achromatopsia is more common than the incomplete form. Its distribution includes pronounced local concentrations. Among Pingelapese islanders in Micronesia in the western Pacific, a reported 4–10% of the population has a total absence of color vision. This range represents complete achromatopsia in a particular population, not the prevalence of common red–green deficiency throughout Micronesia. Numerically, it is approximately 1,200–3,000 times the worldwide estimate for achromatopsia, although the local and worldwide figures do not describe precisely identical diagnostic groupings. (medlineplus.gov)\n\nThe Pingelapese concentration is associated with a founder effect involving the CNGB3 variant p.Ser435Phe, which substitutes phenylalanine for serine at position 435 of the encoded protein. Population histories describe a typhoon around 1775, followed by starvation, that reduced the isolated population to approximately twenty survivors. A founder effect occurs when the descendants of a small, genetically unrepresentative group inherit an unusually high frequency of a particular allele. Subsequent reproduction within the small population can increase the occurrence of a recessive disorder because descendants are more likely to inherit the same pathogenic variant from both parents. This is a population-level consequence of genetic drift, rather than evidence that the condition originated independently in numerous islanders. (sciencerocks.ca)\n\nIn July 2000, Olof H. Sundin and colleagues published molecular evidence linking Pingelapese achromatopsia to a missense variant in CNGB3. Their study narrowed the associated chromosomal interval to 1.4 centimorgans and identified the gene as encoding the beta subunit of the cone cyclic nucleotide-gated channel. This channel participates in converting light stimulation into electrical signals in cone photoreceptors. The molecular finding connected the population’s unusually high prevalence to a specific inherited defect in cone signaling; GeneReviews identifies p.Ser435Phe as the founder variant underlying the Pingelapese concentration. (pubmed.ncbi.nlm.nih.gov)"
    },
    {
      "heading": "Clinical Testing and Diagnosis",
      "text": "Pseudoisochromatic plate tests assess whether a person can distinguish a figure from its background when the principal distinguishing information is color. Their dots vary in size and lightness, reducing the usefulness of outlines or brightness as alternative cues. The observer identifies a number or shape, or traces a winding path through the dots. Colors are selected so that a particular deficiency makes normally distinguishable dots appear similar: a figure may disappear, change into another figure, or become visible only to observers with that deficiency. The Ishihara test primarily screens for inherited red–green deficiencies; it does not include plates for detecting tritan, or blue–yellow, deficiency. Some plates help distinguish protan from deutan responses, but screening performance is not equivalent to a complete classification of the defect. Tracing plates permit assessment without requiring recognition of numerals. Lighting, viewing conditions, and scoring follow the instructions for the particular test edition. (ncbi.nlm.nih.gov)\n\nAn anomaloscope measures color matching rather than recognition of figures. In the classic Nagel Model I instrument, the observer views a circular field divided into two halves. One half contains a variable mixture of approximately 545-nanometer green and 670-nanometer red light; the other contains approximately 589-nanometer yellow light. Separate controls adjust the red–green mixture and the yellow field’s luminance until the halves appear identical in both color and brightness. This procedure is called a Rayleigh match. The examiner records the mixture accepted as a match, the range of acceptable mixtures, and the associated brightness settings. These measurements distinguish typical trichromatic responses from protan and deutan deficiencies and help separate anomalous trichromacy from dichromacy. The task therefore cannot be reduced to naming the lights or simply matching their brightness. (ncbi.nlm.nih.gov)\n\nHue-arrangement tests measure the ability to place colored samples in a perceptually continuous sequence. In the Farnsworth Panel D-15, the observer arranges 15 movable colored caps relative to a reference cap; characteristic crossings in the recorded sequence can indicate an axis of color confusion. The Farnsworth–Munsell 100 Hue test, despite its name, contains 85 movable samples distributed among four trays and provides a more detailed measure of discrimination. Scoring considers departures from the correct order rather than whether the observer knows conventional color names. The standard D-15 chiefly separates substantial deficiencies from normal or mildly impaired discrimination; passing it does not establish normal color vision. Desaturated arrangement tests use less saturated samples to reveal subtler losses, including some acquired disturbances. (ncbi.nlm.nih.gov)\n\nTest selection depends on whether the purpose is rapid screening, classification, measurement of discrimination, or occupational assessment. Suspected blue–yellow loss requires tests capable of detecting that pattern, rather than Ishihara plates alone. Acquired changes may require a combination of matching and arrangement tests; reduced visual acuity can also complicate interpretation of plate-reading errors. Occupational assessment concerns the colors and precision required by the task: matching colors in printing or textiles differs from distinguishing signal lights. A diagnostic label or a single screening result does not by itself measure performance across these different demands. Hue tests are also used when precise discrimination is relevant to work such as graphic design. (ncbi.nlm.nih.gov)\n\nSuspected achromatopsia requires a broader diagnostic assessment, including clinical and family history, visual acuity, examination for nystagmus, color testing, and examination of the retina. A normal-looking fundus does not exclude the disorder; optical coherence tomography can reveal abnormalities of the central retina. Full-field electroretinography records retinal electrical responses under light- and dark-adapted conditions. In achromatopsia, cone-mediated responses—including the 30-hertz flicker response—are absent or markedly reduced, whereas rod-mediated responses are normal or mildly abnormal. Molecular testing can establish the diagnosis by identifying pathogenic or likely pathogenic variants in both copies of an associated gene, such as CNGA3 or CNGB3. Variants of uncertain significance alone do not establish or exclude the diagnosis. (ncbi.nlm.nih.gov)"
    },
    {
      "heading": "Effects on Learning and Everyday Activities",
      "text": "Mild color vision deficiencies may remain unnoticed because the difficulty concerns particular color distinctions rather than every visual task. The National Eye Institute notes that symptoms are often hard to recognize, that people generally adjust to their differences in color perception, and that most affected individuals do not experience problems with everyday activities. Familiar objects and contextual information can remain recognizable even when their colors are difficult to distinguish. Adaptation does not, however, imply that color discrimination has become typical: difficulties may become apparent when an unfamiliar task requires colors to be compared without other identifying information. (nei.nih.gov)\n\nIn education, color can be both the subject of an exercise and the means of communicating its instructions. Learning color names, selecting colored pencils, or reading colored writing on a board can therefore present different obstacles from understanding the underlying lesson. Textbook exercises may require pupils to match objects by color or interpret distinctions in colored illustrations. A study published in 2011 examining textbooks intended for children aged five to seven found that task difficulty depended on the type and degree of color vision deficiency and on ambient illumination. The functional obstacle is thus an interaction between the pupil’s discrimination abilities and the particular material, rather than a uniform inability to use colored educational resources. (nei.nih.gov)\n\nDifficulty with color-dependent activities is not equivalent to a general learning deficit. A 2005 study, Does Daltonism influence young children’s learning?, investigated 1,039 preschool children in Extremadura, Spain. Children with color vision deficiency performed less well on classroom tasks involving color perception, but the investigators found no significant group differences on standard preschool tests of acquired concepts and skills. Teachers who did not yet know which pupils had color vision difficulties nevertheless rated those pupils as somewhat poorer achievers on a curricular-competence questionnaire. These findings distinguish performance on a visually demanding task from broader educational attainment, while showing how color-dependent work can influence judgments of classroom performance. (sciencedirect.com)\n\nEveryday and occupational difficulties become more consequential when accurate color identification is central to the task. The United Kingdom’s Health and Safety Executive lists distinguishing colored wires, traffic signals, road signs, and maps among potential difficulties associated with red–green deficiency. Graphic design is another example identified by the National Eye Institute: work that depends on distinguishing colors may require accommodations even when other activities present little difficulty. A diagnostic label alone does not establish whether someone can perform a particular job. The Health and Safety Executive’s 2005 guidance instead describes a risk-assessment-based approach, relating color vision requirements to actual duties and distinguishing safety-critical judgments from those affecting product quality. Detailed testing procedures and communication-design practices are separate from these functional effects. (hse.gov.uk)\n\nAchromatopsia has broader consequences because impaired color discrimination accompanies reduced visual acuity and photophobia, or increased sensitivity to light. GeneReviews reports best visual acuity of 20/200 or worse in complete achromatopsia, whereas acuity in incomplete achromatopsia may reach 20/80. Consequently, reading classroom material can involve difficulty resolving detail as well as identifying color, and bright daylight or glare can interfere with visual performance. These limitations reflect severe cone dysfunction rather than simply confusion between selected hues. GeneReviews consequently discusses classroom position in relation both to viewing distance and to glare from windows, illustrating why the functional needs of children with achromatopsia differ from those associated with mild inherited red–green deficiency. (ncbi.nlm.nih.gov)"
    },
    {
      "heading": "Accessible Visual Communication",
      "text": "Color-only encoding can make information visible without making its meaning identifiable. A chart may distinguish categories through colored bars but provide no other way to match them to its legend; a form may mark an invalid entry only with a red border; a status indicator may change color without displaying a corresponding label. In each case, recognizing the intended meaning depends on distinguishing the assigned colors. Web Content Accessibility Guidelines (WCAG) Success Criterion 1.4.1, “Use of Color,” is a Level A requirement prohibiting color as the sole visual means of conveying information, indicating an action, prompting a response, or distinguishing an element. WCAG 2.2 became a World Wide Web Consortium Recommendation on October 5, 2023. The criterion does not prohibit color coding: it requires an additional visible distinction wherever color carries meaning. (w3.org)\n\nRedundant encoding associates the same information with text, symbols, shapes, or patterns. W3C technique G111, “Using color and pattern,” illustrates this with a housing-price bar chart in which each region has both a different color and a different fill pattern; the legend reproduces both features. Its transportation-map example distinguishes routes through diamond, square, or circular stop symbols as well as color. A flowchart uses dashed arrows for one outcome and dotted arrows for another, supplementing green and red backgrounds. These distinctions preserve category or route identification when the hues are difficult to separate. The essential mechanism is correspondence: the non-color feature carries the same distinction as the color, rather than merely adding decoration. These are accessibility practices applied to information design, not medical interventions intended to alter color perception. (w3.org)\n\nForms and status displays use the same principle at the level of individual controls. A required field can carry a visible “required” label or an explained symbol; an invalid field can display an error message rather than relying solely on its border color. A colored status marker can likewise be accompanied by text identifying its state. Information supplied only to assistive software does not necessarily satisfy Success Criterion 1.4.1: its purpose includes sighted users who cannot distinguish particular colors and who may not use assistive technology. A visible alternative therefore remains necessary. (w3.org)\n\nLuminance contrast and hue discrimination address different aspects of visibility. WCAG calculates contrast as \\((L_1+0.05)/(L_2+0.05)\\), where \\(L_1\\) and \\(L_2\\) are the relative luminances of the lighter and darker colors. Success Criterion 1.4.3 generally requires a text-to-background ratio of at least \\(4.5:1\\), reduced to \\(3:1\\) for large text, with specified exceptions. Success Criterion 1.4.11 separately requires at least \\(3:1\\) against adjacent colors for visual information needed to identify active controls and their states, and for graphical parts needed to understand content, subject to its exceptions. These requirements concern perceiving text, boundaries, or graphics; they do not by themselves communicate a meaning assigned to a named color. (w3.org)\n\nInline links demonstrate the distinction between identifying an element and identifying its hue. An underline provides a non-color indication that text is a link. Where links lack that indication, W3C technique G183 specifies at least \\(3:1\\) contrast between link text and surrounding non-link text; both must also meet the applicable contrast requirement against their background. Here, lightness supplies the additional distinction. By contrast, a sufficiently contrasting outline does not resolve an instruction that requires recognizing green as “valid” and red as “invalid”: the user must still identify the particular color. Text or another visible state indicator conveys that meaning independently of hue. (w3.org)"
    },
    {
      "heading": "Management, Assistive Technology, and Therapeutic Research",
      "text": "Common inherited red–green color vision deficiencies have no established cure. Management chiefly involves accommodations and assistive devices rather than correction of the underlying biological condition. These approaches can make a particular task easier without changing the inherited defect or restoring typical color discrimination. Acquired deficiencies are managed differently: treatment addresses the condition responsible for the change, while medication-associated disturbances may lead to clinician-directed changes in medication or dosage. This is distinct from treating inherited deficiency with an optical aid. (nei.nih.gov)\n\nFiltered spectacles and tinted contact lenses selectively alter the light reaching the eye, changing the relative appearance and contrast of colors. Their effects depend on the filter, the observer’s deficiency, and the colors being compared; an improvement for one combination does not establish a general restoration of color vision. In a 2022 study, Cat Pattie, Stacey Aston, and Gabriele Jordan compared 86 participants with classified color vision deficiencies and 24 controls on two clinical tests. EnChroma notch-filter spectacles produced no overall improvement, with results indicating better discrimination for some colors and worse discrimination for others. A separate 2020 experiment involving nine color-deficient participants and five controls likewise found task-specific effects rather than a general correction: filters increased protan-type errors in deutan participants and impaired the naming of cyan stimuli. Such findings distinguish changes in visual appearance or selected test performance from recovery of typical color perception. (pubmed.ncbi.nlm.nih.gov)\n\nColor-identification applications provide information through a different route. A user can photograph an object with a smartphone or tablet and select part of the image to obtain its color name. The application supplies a label rather than enabling the eye to discriminate that color directly. Severe cone disorders such as achromatopsia require broader support because reduced acuity and photophobia accompany the color-discrimination deficit. Dark or specially filtered spectacles and red-tinted contact lenses are used to reduce photophobia and may improve usable visual acuity. High-powered reading magnifiers and electronic magnification address difficulty seeing fine detail, while vision rehabilitation can include training in assistive-device use and adaptations for daily activities. These functions differ from the selective contrast modification sought with filters for common red–green deficiencies. (nei.nih.gov)\n\nExperimental gene therapy for achromatopsia instead targets impaired cone function. Investigated approaches use an adeno-associated viral vector to deliver a functional copy of CNGA3 or CNGB3 to retinal cells through a subretinal injection. In a nonrandomized clinical trial reported in 2020, M. Dominik Fischer and colleagues treated nine adults with genetically confirmed CNGA3-associated achromatopsia. At 12 months, treated eyes showed a mean visual-acuity gain of 2.9 letters and a mean contrast-sensitivity improvement of 0.33 log units; no substantial safety problems were observed during that follow-up. These measured gains were not equivalent to restoration of normal vision, and the small, open-label study was exploratory. (pubmed.ncbi.nlm.nih.gov)\n\nA phase 1/2 study reported by Michel Michaelides and colleagues in 2023 investigated CNGB3 gene delivery in 23 participants: 11 adults and 12 children. At 24 weeks, there was no consistent pattern of improvement across efficacy assessments, although individual favorable changes included color-vision measures in six participants and reduced light aversion in 11 of 20 assessed participants. Intraocular inflammation occurred in nine participants, with two events considered serious and dose-limiting; the inflammation resolved following corticosteroid treatment. The study supported continued investigation, not adoption as an established cure. Its outcomes also illustrate why safety, color discrimination, visual acuity, and light sensitivity are assessed separately when evaluating a treatment for a severe inherited cone disorder. (pubmed.ncbi.nlm.nih.gov)"
    },
    {
      "heading": "History of Scientific Investigation",
      "text": "In 1794, John Dalton presented an account of his unusual color perception to the Manchester Literary and Philosophical Society. He recognized that his brother perceived colors similarly, an observation that suggested a hereditary explanation rather than an individual peculiarity. His investigation became an influential early scientific description of color vision deficiency, and his name supplied the historical term Daltonism. The account subsequently appeared in 1798 as “Extraordinary facts relating to the vision of colours.” Dalton’s approach combined comparisons with other observers and observations under different lighting conditions, making differences in perception a subject of systematic investigation. (royalsociety.org)\n\nDalton proposed that his vitreous humor—the transparent, gel-like material within the eye—had an abnormal blue tint. Such a filter, he reasoned, would selectively absorb longer wavelengths before light reached the retina. He requested that his eyes be examined after death to test this explanation. Following his death in 1844, examination revealed that their contents were colorless, contradicting the proposed filtering mechanism. The observation rejected a specific anatomical hypothesis without yet establishing the biological cause of his color confusions. Preserved eye tissue later made it possible to investigate the same case using methods unavailable during Dalton’s lifetime. (royalsociety.org)\n\nA milestone in standardized screening was the first publication of the Ishihara test in Japan in 1917. Its colored plates transformed particular color confusions into repeatable recognition tasks rather than relying entirely on descriptions of subjective experience. The test subsequently appeared in multiple editions and was widely used in color vision assessment. Its institutional adoption is illustrated by the United States Health Examination Survey of 1963–1965: seven plates selected from the 24-plate 1960 edition were used to screen children aged 6–11. These required recognition of one or two colored numerals, or recognition that no numeral was present. Children’s responses were then supplemented by another plate test for classification, distinguishing screening from more detailed assessment. (cdc.gov)\n\nOn February 17, 1995, David M. Hunt, Kanwaljit S. Dulai, James K. Bowmaker, and John D. Mollon published “The Chemistry of John Dalton’s Color Blindness” in Science. Analysis of DNA extracted from Dalton’s preserved eye tissue identified him as a deuteranope, lacking the retinal middle-wavelength-sensitive photopigment. This molecular finding contradicted Thomas Young’s earlier interpretation that Dalton lacked the red-sensitive contribution to vision. The investigators also checked their conclusion against Dalton’s recorded observations: he had described red sealing wax as matching a laurel leaf and pink flowers as appearing blue in daylight. The study thus connected an individual’s historical descriptions with the underlying photopigment defect, replacing the rejected tinted-vitreous explanation with evidence from molecular biology. (pubmed.ncbi.nlm.nih.gov)"
    }
  ],
  "links": [
    "brain",
    "genetics",
    "diagnosis",
    "education",
    "gene",
    "glaucoma",
    "multiple-sclerosis",
    "cataract",
    "light",
    "electromagnetic-spectrum",
    "x-chromosome",
    "dna",
    "gene-expression",
    "protein",
    "allele",
    "genotype",
    "phenotype",
    "prevalence",
    "genetic-drift",
    "smartphone",
    "rehabilitation",
    "gene-therapy",
    "clinical-trial",
    "john-dalton",
    "molecular-biology"
  ],
  "sources": [
    {
      "title": "Color Blindness | National Eye Institute",
      "url": "https://www.nei.nih.gov/eye-health-information/eye-conditions-and-diseases/color-blindness"
    },
    {
      "title": "Color vision deficiency: MedlinePlus Genetics",
      "url": "https://www.medlineplus.gov/genetics/condition/color-vision-deficiency/"
    },
    {
      "title": "Causes of Color Vision Deficiency | National Eye Institute",
      "url": "https://www.nei.nih.gov/eye-health-information/eye-conditions-and-diseases/color-blindness/causes-color-vision-deficiency"
    },
    {
      "title": "Achromatopsia: MedlinePlus Genetics",
      "url": "https://www.medlineplus.gov/genetics/condition/achromatopsia/"
    },
    {
      "title": "Color vision deficiency: MedlinePlus Genetics",
      "url": "https://medlineplus.gov/genetics/condition/color-vision-deficiency/"
    },
    {
      "title": "How the Eyes Work",
      "url": "https://www.nei.nih.gov/eye-health-information/healthy-vision/how-eyes-work"
    },
    {
      "title": "Absorption spectra of human cone pigments",
      "url": "https://pubmed.ncbi.nlm.nih.gov/1557124/"
    },
    {
      "title": "The 'blue-on' opponent pathway in primate retina originates from a distinct bistratified ganglion cell type.",
      "url": "https://pubmed.ncbi.nlm.nih.gov/8107868/"
    },
    {
      "title": "Types of Color Vision Deficiency",
      "url": "https://www.nei.nih.gov/eye-health-information/eye-conditions-and-diseases/color-blindness/types-color-vision-deficiency"
    },
    {
      "title": "Protan defect - NIH Genetic Testing Registry (GTR)",
      "url": "https://www.ncbi.nlm.nih.gov/gtr/conditions/C0155015/"
    },
    {
      "title": "CLASSIFICATION OF COLOR VISION DEFECTS - Procedures for Testing Color Vision",
      "url": "https://www.ncbi.nlm.nih.gov/books/NBK217820/"
    },
    {
      "title": "Achromatopsia - GeneReviews®",
      "url": "https://www.ncbi.nlm.nih.gov/books/NBK1418/?report=reader"
    },
    {
      "title": "Achromatopsia - GeneReviews®",
      "url": "https://www.ncbi.nlm.nih.gov/sites/books/NBK1418/?report=reader"
    },
    {
      "title": "Blue cone monochromatism",
      "url": "https://www.blueconemonochromacy.org/wp-content/uploads/2011/02/6701391a.pdf"
    },
    {
      "title": "OPN1LW gene: MedlinePlus Genetics",
      "url": "https://medlineplus.gov/genetics/gene/opn1lw/"
    },
    {
      "title": "What are the different ways a genetic condition can be inherited?: MedlinePlus Genetics",
      "url": "https://medlineplus.gov/genetics/understanding/inheritance/inheritancepatterns/"
    },
    {
      "title": "OPN1SW gene: MedlinePlus Genetics",
      "url": "https://medlineplus.gov/genetics/gene/opn1sw/"
    },
    {
      "title": "Achromatopsia: MedlinePlus Genetics",
      "url": "https://medlineplus.gov/genetics/condition/achromatopsia/"
    },
    {
      "title": "CNGA3 gene: MedlinePlus Genetics",
      "url": "https://medlineplus.gov/genetics/gene/cnga3/"
    },
    {
      "title": "Causes of Cataracts",
      "url": "https://www.nei.nih.gov/eye-health-information/eye-conditions-and-diseases/cataracts/causes-cataracts?services=49&topics=87&types=BSC.Blog"
    },
    {
      "title": "Glaucoma",
      "url": "https://www.nei.nih.gov/eye-health-information/eye-conditions-and-diseases/glaucoma"
    },
    {
      "title": "The visual defect in multiple sclerosis and optic neuritis. A combined psychophysical and electrophysiological investigation.",
      "url": "https://pubmed.ncbi.nlm.nih.gov/1782524/"
    },
    {
      "title": "The dyschromatopsia of optic neuritis: a descriptive analysis of data from the optic neuritis treatment trial",
      "url": "https://pubmed.ncbi.nlm.nih.gov/8719696/"
    },
    {
      "title": "Impaired colour discrimination among workers exposed to styrene: relevance of a urinary metabolite",
      "url": "https://pubmed.ncbi.nlm.nih.gov/7663639/"
    },
    {
      "title": "Achromatopsia - GeneReviews® - NCBI Bookshelf",
      "url": "https://www.ncbi.nlm.nih.gov/books/NBK1418/"
    },
    {
      "title": "Opsin genes, cone photopigments, color vision, and color blindness",
      "url": "https://sciencerocks.ca/wp-content/uploads/2014/07/sharpe-opsin-genes.pdf"
    },
    {
      "title": "Genetic basis of total colourblindness among the Pingelapese islanders - PubMed",
      "url": "https://pubmed.ncbi.nlm.nih.gov/10888875/"
    },
    {
      "title": "COLOR VISION TESTS - Procedures for Testing Color Vision",
      "url": "https://www.ncbi.nlm.nih.gov/books/NBK217823/?report=printable"
    },
    {
      "title": "COLOR VISION TESTS - Procedures for Testing Color Vision",
      "url": "https://www.ncbi.nlm.nih.gov/books/NBK217823/?report=reader"
    },
    {
      "title": "CLASSIFICATION OF COLOR VISION DEFECTS - Procedures for Testing Color Vision",
      "url": "https://www.ncbi.nlm.nih.gov/books/NBK217820/?report=classic"
    },
    {
      "title": "TESTS OF VISUAL FUNCTIONS - Visual Impairments",
      "url": "https://www.ncbi.nlm.nih.gov/books/NBK207559/?report=reader"
    },
    {
      "title": "The Perception of Color - Webvision",
      "url": "https://www.ncbi.nlm.nih.gov/books/NBK11538/"
    },
    {
      "title": "USING COLOR VISION TESTS - Procedures for Testing Color Vision",
      "url": "https://www.ncbi.nlm.nih.gov/books/NBK217826/?report=printable"
    },
    {
      "title": "RECOMMENDATIONS - Procedures for Testing Color Vision",
      "url": "https://www.ncbi.nlm.nih.gov/books/NBK217817/"
    },
    {
      "title": "Testing for Color Vision Deficiency",
      "url": "https://www.nei.nih.gov/eye-health-information/eye-conditions-and-diseases/color-blindness/testing-color-vision-deficiency"
    },
    {
      "title": "Achromatopsia - GeneReviews",
      "url": "https://www.ncbi.nlm.nih.gov/sites/books/NBK1418/?report=printable"
    },
    {
      "title": "Guidance Note MS7 - Colour vision examination: A guide for occupational health providers",
      "url": "https://www.hse.gov.uk/pubns/ms7.pdf"
    },
    {
      "title": "Colour vision examination - HSE",
      "url": "https://www.hse.gov.uk/PUBNS/ms7.htm"
    },
    {
      "title": "Achromatopsia",
      "url": "https://www.ncbi.nlm.nih.gov/books/NBK1418/pdf/Bookshelf_NBK1418.pdf"
    },
    {
      "title": "Understanding Success Criterion 1.4.1: Use of Color",
      "url": "https://www.w3.org/WAI/WCAG22/Understanding/use-of-color.html?trk=public_post_comment-text"
    },
    {
      "title": "WCAG 2.2 is a Web Standard \"W3C Recommendation\"",
      "url": "https://www.w3.org/WAI/news/2023-10-05/wcag22rec/"
    },
    {
      "title": "G111: Using color and pattern",
      "url": "https://www.w3.org/WAI/WCAG22/Techniques/general/G111"
    },
    {
      "title": "Understanding Success Criterion 1.4.3: Contrast (Minimum)",
      "url": "https://www.w3.org/WAI/WCAG22/Understanding/contrast-minimum.html"
    },
    {
      "title": "Understanding Success Criterion 1.4.11: Non-text Contrast",
      "url": "https://www.w3.org/WAI/WCAG22/understanding/non-text-contrast.html"
    },
    {
      "title": "G183: Using a contrast ratio of at least 3:1 to distinguish inline text links from surrounding text",
      "url": "https://www.w3.org/WAI/WCAG22/Techniques/general/G183"
    },
    {
      "title": "Do EnChroma glasses improve performance on clinical tests for red-green color deficiencies?",
      "url": "https://pubmed.ncbi.nlm.nih.gov/36242261/"
    },
    {
      "title": "Characterizing the Effects of Enchroma Glasses on Color Discrimination.",
      "url": "https://pubmed.ncbi.nlm.nih.gov/33055508/"
    },
    {
      "title": "Vision Rehabilitation Resources | National Eye Institute",
      "url": "https://www.nei.nih.gov/about/education-and-outreach/vision-rehabilitation-resources"
    },
    {
      "title": "Safety and Vision Outcomes of Subretinal Gene Therapy Targeting Cone Photoreceptors in Achromatopsia: A Nonrandomized Controlled Trial",
      "url": "https://pubmed.ncbi.nlm.nih.gov/32352493/"
    },
    {
      "title": "First-in-Human Gene Therapy Trial of AAV8-hCARp.hCNGB3 in Adults and Children With CNGB3-associated Achromatopsia",
      "url": "https://pubmed.ncbi.nlm.nih.gov/37172884/"
    },
    {
      "title": "John Dalton FRS - Scientists with disabilities | Royal Society",
      "url": "https://royalsociety.org/about-us/who-we-are/diversity-inclusion/case-studies/scientists-with-disabilities/john-dalton/"
    },
    {
      "title": "Vital and Health Statistics; Series 11, No. 118 (8/72)",
      "url": "https://www.cdc.gov/nchs/data/series/sr_11/sr11_118.pdf"
    },
    {
      "title": "The chemistry of John Dalton's color blindness - PubMed",
      "url": "https://pubmed.ncbi.nlm.nih.gov/7863342/"
    },
    {
      "title": "The Chemistry of John Dalton’s Color Blindness",
      "url": "https://www.columbia.edu/itc/biology/pollack/w4065/client_edit/readings/science265_984.pdf"
    }
  ],
  "license": "https://creativecommons.org/licenses/by/4.0/"
}